Lindi Slevin

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The complex procedure of processing the marketing authorisation of medicinal product licences is a challenging task for government health authorities and the pharmaceutical industry across the world. Regulatory requirements have diverged significantly, and each country has its own regulations and procedures for marketing authorisations. The automation of(More)
  • 1